These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3054457)

  • 21. A double-blind study of Inderex in the treatment of essential hypertension.
    Crowe PF; Finnegan OC; Russell CJ; Varma MP
    Br J Clin Pract; 1987 Oct; 41(10):967-70. PubMed ID: 3333146
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of hypertension with alpha blockade or ACE inhibition. Multicenter double-blind study of urapidil versus captopril].
    Rosenthal J; Haerlin R
    Fortschr Med; 1986 Oct; 104(40):763-6. PubMed ID: 3536700
    [No Abstract]   [Full Text] [Related]  

  • 23. [Controlled clinical study of use of dihydroergocristine in cerebral and periferal vascular disorders].
    Calisti G; Biscarini L; Miseo A
    Clin Ter; 1977 Nov; 83(4):371-86. PubMed ID: 414875
    [No Abstract]   [Full Text] [Related]  

  • 24. [Fenquizone in the medium term treatment of essential hypertension. Double-blind comparison with chlorthalidone and placebo].
    Pasotti C; Rossi R; Gandolfi P
    Minerva Med; 1981 Nov; 72(46):3105-10. PubMed ID: 7029355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Placebo controlled double-blind randomised cross-over trial of atenolol, hydrochlorothiazide and amiloride, and the combination (Kalten) in patients over 60 years of age.
    Jackson G; Rowland M; Adam G; MacFarlane E; Jackson PG
    Br J Clin Pract; 1986 Jun; 40(6):230-4. PubMed ID: 3527246
    [No Abstract]   [Full Text] [Related]  

  • 26. Piretanide in the treatment of essential hypertension. A double-blind comparison versus placebo.
    Verho M; Rangoonwala B; Beloso M; Maass L; Bender R; Garduno D
    Drugs Exp Clin Res; 1986; 12(5):385-91. PubMed ID: 3522159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A randomized comparison between acebutolol and metoprolol in 215 patients with hypertension. Significance of the self-stimulating effect and awareness of the occurrence of adverse effects].
    Heebøll-Nielsen NC; Carlsen JE
    Ugeskr Laeger; 1988 Apr; 150(15):912-5. PubMed ID: 3284132
    [No Abstract]   [Full Text] [Related]  

  • 28. The efficacy and safety of enalapril in moderate to severe essential hypertension.
    Walker JF; Kulaga SF; Kramsch DM
    J Hypertens Suppl; 1984 Dec; 2(2):S107-11. PubMed ID: 6100871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A new dihydroergotoxine preparation for hypertension in the aged. Study of effectiveness and tolerance in a placebo-controlled trial].
    Schuback G; Rogalla K
    Fortschr Med; 1987 Oct; 105(31):617-20. PubMed ID: 3319850
    [No Abstract]   [Full Text] [Related]  

  • 30. Double-blind cross-over clinical trial of acebutolol and propranolol in mild to moderate essential hypertension.
    Pandhi P; Sethi V; Sharma BK; Wahl PL; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):606-8. PubMed ID: 3908332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Double-blind, placebo-controlled trial of twice-daily nifedipine as a step-2 agent in mild essential hypertension.
    Svetkey LP; Weinberger MH; Gavras H; Gavras I; Brown TS; Deterding J; Klotman PE
    J Clin Hypertens; 1987 Dec; 3(4):579-88. PubMed ID: 3330988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Double-blind comparison of Inderal LA (160 mg), Half-Inderal LA (80 mg), and Half-Inderal LA plus bendrofluazide (2.5 mg) in the treatment of elderly hypertensive patients.
    Agrawal RL
    Br J Clin Pract; 1987 Sep; 41(9):916-20. PubMed ID: 3330455
    [No Abstract]   [Full Text] [Related]  

  • 33. Transdermal clonidine in mild hypertension. A randomized, double-blind, placebo-controlled trial.
    Popli S; Daugirdas JT; Neubauer JA; Hockenberry B; Hano JE; Ing TS
    Arch Intern Med; 1986 Nov; 146(11):2140-4. PubMed ID: 3535714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double-blind, randomized, cross-over clinical trial of metoprolol and propranolol in mild to moderate essential hypertension.
    Pandhi P; Sahai J; Wahi PL; Sharma BK; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):163-5. PubMed ID: 3549583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atenolol in hypertension.
    Misra NP; Bahadur MM
    J Assoc Physicians India; 1984 Oct; 32(10):863-6. PubMed ID: 6394581
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical evaluation of a new preparation of Ersilan drops in patients with vascular headaches].
    Serclová L
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1988; 31(5):649-55. PubMed ID: 3155391
    [No Abstract]   [Full Text] [Related]  

  • 37. Acebutolol and nifedipine in the treatment of arterial hypertension: efficacy and acceptability.
    de Divitiis O; Petitto M; Di Somma S; Fazio S; Galderisi M; Villari B; Liguori V; Santomauro M
    Arzneimittelforschung; 1984; 34(6):710-5. PubMed ID: 6386007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Methodology of a controlled trial of dihydroergotoxine in acquired intellectual impairment in the adult].
    Dartigues JF; Père JJ
    Presse Med; 1983 Dec; 12(48):3173-5. PubMed ID: 6228936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peripheral dopamine receptors in the antihypertensive action of dihydroergotoxine in humans.
    Mercuro G; Rossetti ZL; Rivano CA; Ruscazio M; Tocco L; Gessa G; Cherchi A
    Hypertension; 1987 Jan; 9(1):35-40. PubMed ID: 3793199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A double blind comparison of indoramin with clonidine in the treatment of moderate to severe essential hypertension.
    Yajnik BH; Shah JS
    J Assoc Physicians India; 1985 May; 33(5):339-43. PubMed ID: 3900029
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.